ARNI Combined With SGLT2 Inhibitors on Functional Mitral Regurgitation Remodeling — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ARNI Combined With SGLT2 Inhibitors on Functional Mitral Regurgitation Remodeling — Stella

Home/Heart Failure/

View on ClinicalTrials.gov

Recruiting

Back to Heart Failure trials

Trial locations(1 site)

Saudi Arabia

Madinah Cardiac Center, Madinah

Key details

Sponsor

Rehab Werida

Collaborators

Tanta University, Madinah Cardiac Center in Madinah, KSA.

Enrollment target

~180 participants

Started

December 2025

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.